Actively Recruiting
The Study of Ginkgo Leaf Dropping Pills and Huperzine a Injection Combined with Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury
Led by Wanbangde Pharmaceutical Group Co., LTD · Updated on 2024-12-11
50
Participants Needed
1
Research Sites
143 weeks
Total Duration
On this page
Sponsors
W
Wanbangde Pharmaceutical Group Co., LTD
Lead Sponsor
G
Ganzhou City People's Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will conduct a single-center clinical trial to explore the initial therapeutic effect of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment.
CONDITIONS
Official Title
The Study of Ginkgo Leaf Dropping Pills and Huperzine a Injection Combined with Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be over 18 years old
- Have residual cognitive impairment caused by brain injury
- Have no previous history of brain-related diseases other than this brain injury
You will not qualify if you...
- Have severe underlying diseases with unstable vital signs
- Have consciousness disorders preventing cooperation with cognitive assessments
- Are allergic to any study drugs or have contraindications for drug use
- Have contraindications for median nerve electrical stimulation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Ganzhou City People's Hospital
Ganzhou, Jiangxi, China, 8112320
Actively Recruiting
Research Team
D
Dong Wang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here